Abstract
Efficacy subgroup analyses from the phase 3 CHAMPION-NMOSD trial in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (S5.003)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have